NCT06601634

Brief Summary

Neck pain is a common, multifactorial condition. In the case of degenerative cervical spinal disease, it can result from changes in the intervertebral discs, muscles, intervertebral joints, or sagittal imbalance. Anterior cervical discectomy and fusion (ACDF) is a currently widely accepted procedure for treating cervical degenerative spine disease, with a high patient satisfaction rate. In the current state of knowledge, it is not used for treating axial neck pain, but rather in cases of discopathy causing spinal myelopathy or cervical radiculopathy, in which neck pain often coexists or predominates. The current literature provides ample evidence of the significant effect of ACDF in improving axial neck pain in the conditions mentioned previously. However, little information exists on which patients achieve improvement. The aim of this prospective study is to analyze the outcomes of ACDF in patients with neck pain and to identify predictors of reduction in axial neck pain after ACDF.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Nov 2024Dec 2027

First Submitted

Initial submission to the registry

September 14, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

November 17, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2027

Expected
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

3 years

First QC Date

September 14, 2024

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Predictors of the reduction of axial neck pain following ACDF.

    Change in VAS neck pain ( visual analog scale), with calculated MCID ( Minimal Clinically Important Difference) as 2.5

    On the day of discharge from the hospital, at 6 months, 1 year, 2 years

  • Predictors of functional outcomes following ACDF.

    Change in NDI ( neck disability index), with calculated MCID as 7.5

    On the day of discharge from the hospital, at 6 months, 1 year, 2 years

Secondary Outcomes (2)

  • Predictors of the reduction of axial neck pain following ACDF in population with predominant neck pain.

    On the day of discharge from the hospital, at 6 months, 1 year, 2 years

  • Predictors of functional outcomes following ACDF in population with predominant neck pain.

    On the day of discharge from the hospital, at 6 months, 1 year, 2 years

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We plan to prospectively enroll at least 60 patients who are qualified for one- or two-level ACDF for the treatment of degenerative cervical pathology with significant neck pain, and to identify predictors of the reduction in axial neck pain following surgery.

You may qualify if:

  • Ability to provide informed consent
  • Patients who are qualified for one- or two-level ACDF for the treatment of degenerative cervical pathology

You may not qualify if:

  • Previous cervical spine surgery
  • Previous cervical spine trauma
  • Other diseases causing neck pain include rheumatoid arthritis, lupus, polymyalgia rheumatica, myositis, seronegative inflammatory diseases, and fibromyalgia
  • Drug abuse
  • Myelopathy
  • Spinal infection
  • VAS neck pain score less than 3 (Inability to achieve an MCID which is calculated as 2.5 for the VAS scale)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Orthopaedics, J. Dietl Specialist Hospital

Krakow, Lesser Poland Voivodeship, 30-119, Poland

RECRUITING

Department of Neurosurgery, Medical University of Warsaw

Warsaw, Masovian Voivodeship, 02-097, Poland

RECRUITING

MeSH Terms

Conditions

Neck PainSpondylosis

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Central Study Contacts

Jan Chrzanowski, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 14, 2024

First Posted

September 19, 2024

Study Start

November 17, 2024

Primary Completion (Estimated)

November 17, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

March 26, 2025

Record last verified: 2025-03

Locations